Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma

A. Spiegel, M. Greene, I. Magrath, J. Balow, S. Marx, G. D. Aurbach

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Two patients with Burkitt's lymphoma presented with severe hypercalcemia, a previously unreported complication of this tumor. Roentgenograms and radionuclide scans showed multiple osteolytic lesions in both patients. Plasma parathyroid hormone (PTH) was undetectable during the hypercalcemic phase. Chemotherapy was followed by rapid tumor lysis, hyperphosphatemia, phosphaturia and hypocalcemia. The hypocalcemic phase persisted for two weeks despite rapid normalization of serum phosphorus and renal function. Measurement of urinary cyclic AMP, an index of PTH action, indicated that parathyroid function had been suppressed by the hypercalcemia and remained suppressed for almost one week despite marked hypocalcemia.

Original languageEnglish (US)
Pages (from-to)691-695
Number of pages5
JournalThe American Journal of Medicine
Issue number4
StatePublished - Apr 1978
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma'. Together they form a unique fingerprint.

Cite this